This 2010 'Classifications in Brief' article reviews the Enneking surgical staging system for musculoskeletal tumors. Originally developed in 1977 and adopted by the Musculoskeletal Tumor Society and AJCC in 1980, it provides separate staging frameworks for benign and malignant mesenchymal tumors. The article covers the system's structure, validation data, comparison with the AJCC TGNM system, and key limitations.
Every musculoskeletal tumor you stage with Enneking is being evaluated through two lenses: how aggressive is the biology (grade), and how far has it spread anatomically (compartment). Those two variables directly determine how wide your resection must be and whether adjuvant therapy is warranted.
When you see a high-grade sarcoma (G2) that has crossed compartmental boundaries (T2), that is Stage IIB — the stage where limb salvage requires wide margins and adjuvant therapy is standard. When a patient presents with any sarcoma and known metastases, the stage is III regardless of grade or local extent. Metastasis overrides everything else.
Know the exclusions cold for boards and for clinic: Ewing's sarcoma, lymphoma, myeloma, and metastatic carcinoma are NOT staged with Enneking. For spinal primaries, add the WBB classification to capture epidural involvement and stability considerations that Enneking alone cannot address.
The AJCC TGNM system uses a 5 cm size cutoff instead of compartmental anatomy. Useful for soft tissue sarcomas but limited for surgical planning, which is why Enneking remains the standard for orthopedic oncologists.
This 2010 'Classifications in Brief' article reviews the Enneking surgical staging system for musculoskeletal tumors. Originally developed in 1977 and adopted by the Musculoskeletal Tumor Society and AJCC in 1980, it provides separate staging frameworks for benign and malignant mesenchymal tumors. The article covers the system's structure, validation data, comparison with the AJCC TGNM system, and key limitations.
Every musculoskeletal tumor you stage with Enneking is being evaluated through two lenses: how aggressive is the biology (grade), and how far has it spread anatomically (compartment). Those two variables directly determine how wide your resection must be and whether adjuvant therapy is warranted.
When you see a high-grade sarcoma (G2) that has crossed compartmental boundaries (T2), that is Stage IIB — the stage where limb salvage requires wide margins and adjuvant therapy is standard. When a patient presents with any sarcoma and known metastases, the stage is III regardless of grade or local extent. Metastasis overrides everything else.
Know the exclusions cold for boards and for clinic: Ewing's sarcoma, lymphoma, myeloma, and metastatic carcinoma are NOT staged with Enneking. For spinal primaries, add the WBB classification to capture epidural involvement and stability considerations that Enneking alone cannot address.
The AJCC TGNM system uses a 5 cm size cutoff instead of compartmental anatomy. Useful for soft tissue sarcomas but limited for surgical planning, which is why Enneking remains the standard for orthopedic oncologists.